Related Experiment Video
Updated: Jun 18, 2026

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
A Nonparametric Alternative to Modeling Population Pharmacokinetics in Patients with Spinal Cord Injury: Comparison
Jack L. Segal1, Thomas M. Gilman, Sherry R. Brunnemann
1Medical and Spinal Cord Injury Service, Department of Veterans Affairs Medical Center, Long Beach, USA, and Department of Medicine, University of California, Irvine, USA.
Abstract:
The estimation of population-specific pharmacokinetic parameters from sparse of fragmentary data obtained during routine patient care is a powerful analytical tool in drug development and therapeutic drug monitoring. The Nonparametric Expectation Maximization program (NPEM) performs this function and generates robust parameter estimates which are distribution-free and unconstrained by assumption-rich parametric, for example, Gaussian, analyses. We compared standard two-stage method (STS) estimates of amikacin pharmacokinetic parameters (V, CL) derived from a sampling rich strategy (11 patients with spinal cord injury, SCI; 7 able-bodied controls) to estimates of pharmacokinetic parameters obtained from an NPEM one-compartment analysis incorporating the 11 optimally sampled SCI patients and 8 sparse data sets (19 patients with SCI; 7 controls). The STS (n = 11) and NPEM (n = 19) analyses provided similar V and CL parameter estimates in patients with SCI: 0.20 plus minus 0.04 L kg(minus sign1), 0.93 plus minus 0.24 ml min(minus sign1) kg(minus sign1) and 0.20 plus minus 0.06 L kg(minus sign1), 1.12 plus minus 0.26 ml min(minus sign1) kg(minus sign1), respectively. NPEM is a useful, user-friendly, distribution-free computational program for estimating the central tendency and interindividual variability of amikacin pharmacokinetic parameters in spinal cord injured humans.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Dosage Regimens: Partial Pharmacokinetic Parameters

